Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06486467

Reliability of Minimally Trained Operator's Velocity-Time Integral Measurement Guided by Artificial Intelligence VTI

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-04-21

100

Participants Needed

3

Research Sites

78 weeks

Total Duration

On this page

Sponsors

A

Assistance Publique - Hôpitaux de Paris

Lead Sponsor

P

Philips Healthcare

Collaborating Sponsor

AI-Summary

What this Trial Is About

Stroke volume is a major determinant of tissue perfusion and therefore a key parameter to monitor in patients with hemodynamic instability and hypoperfusion. Left Ventricular Outflow Tract (LVOT) Velocity-Time Integral (VTI) measured using pulsed wave Doppler is widely used as an estimation of stroke volume and should be a competence required for every Intensive Care Unit (ICU) physician. Recently, research in Artificial Intelligence (AI) applied to medical imaging constituted a breakthrough in the acquisition of images. The goal of the present study is to characterize and quantify the reliability and reproducibility of LVOT VTI measurements by comparing the measures obtained by minimally-trained operators and expert physicians, guided by UltraSight AI software.

CONDITIONS

Official Title

Reliability of Minimally Trained Operator's Velocity-Time Integral Measurement Guided by Artificial Intelligence VTI

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 years and older
  • Hospitalized in ICU and considered in need of fluid administration based on hypoperfusion signs such as more than 10% decrease in mean arterial pressure, skin mottling, low urine output, changes in consciousness, high lactate levels, or low central venous oxygen saturation
  • Affiliated with a French social security system (beneficiary or legal)
  • Participant or next of kin does not object or emergency procedure allows inclusion
Not Eligible

You will not qualify if you...

  • Patients with atrial fibrillation
  • Patients receiving Emergency Medical Assistance
  • Patients under guardianship, curatorship, or deprived of liberty

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

CHU de Limoges

Limoges, France, 87042

Not Yet Recruiting

2

Hôpital Lariboisière - APHP

Paris, France, 75010

Actively Recruiting

3

Hôpital européen Georges Pompidou - APHP

Paris, France, 75015

Actively Recruiting

Loading map...

Research Team

B

Bernard Cholley

CONTACT

C

Cléo Bourgeois

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here